Mitochondrial dysfunction and molecular pathways of disease.
about
Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the diseaseMyalgic encephalomyelitis: International Consensus CriteriaChronic fatigue syndrome and mitochondrial dysfunctionCancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexateNeuropharmacological Potential of Gastrodia elata Blume and Its ComponentsA review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditionsEffect of redox modulating NRF2 activators on chronic kidney diseaseDissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycinOxidant Mechanisms in Renal Injury and DiseaseDifferential mitochondrial toxicity screening and multi-parametric data analysisMitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndromeA mitochondrial DNA hypomorph of cytochrome oxidase specifically impairs male fertility in Drosophila melanogasterVitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults.A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer.Loss of dihydrolipoyl succinyltransferase (DLST) leads to reduced resting heart rate in the zebrafish.Power to detect risk alleles using genome-wide tag SNP panelsReciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time.A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis.The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis.Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.Mitochondrial dysfunction links ceramide activated HRK expression and cell death.Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature.Coenzyme q10 abrogated the 28 days aluminium chloride induced oxidative changes in rat cerebral cortex.A metabonomic comparison of urinary changes in Zucker and GK rats.Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity.Inhibition of neuronal cell mitochondrial complex I with rotenone increases lipid β-oxidation, supporting acetyl-coenzyme A levels.High glucose predisposes gene expression and ERK phosphorylation to apoptosis and impaired glucose-stimulated insulin secretion via the cytoskeletonExpression profiles of mitochondrial genes in the frontal cortex and the caudate nucleus of developing humans and mice selectively bred for high and low fearEffects of physical exercise on central nervous system functions: a review of brain region specific adaptationsIdentification of miRNAs involved in pear fruit development and quality.Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.SOD2, the principal scavenger of mitochondrial superoxide, is dispensable for embryogenesis and imaginal tissue development but essential for adult survivalLower oxidative DNA damage despite greater ROS production in muscles from rats selectively bred for high running capacity.Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential.Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Confocal imaging of single mitochondrial superoxide flashes in intact heart or in vivoNitric oxide and mitochondria in metabolic syndrome.Oscillatory shear stress induces mitochondrial superoxide production: implication of NADPH oxidase and c-Jun NH2-terminal kinase signalingA rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.
P2860
Q21195362-B5B0BB0D-3EB9-4422-A7EB-B1239D63A217Q24611510-560902B0-8B87-45D8-BA67-48B195A72C73Q24647385-8495DE86-696A-4862-99FF-5767F14F9932Q26775475-2508BDBC-93E4-4B17-AA3B-CDB40AC22363Q26778823-7267636D-DF0C-459E-8FBA-B12D1BB442DAQ26781560-3B468659-D12A-4A06-B966-968984E7241FQ26827726-E870106C-21DC-4E2F-9423-B14A2838F912Q27681169-F47D37B8-B859-4866-90EF-C99254E67A45Q28384392-C987FE9F-6DB4-4FE5-B88B-F8F0236C6374Q28484406-593E8F0D-5828-46FA-99A3-42C5E92CA6E7Q28650861-58EA6813-6A38-4FB1-AA3B-58B908CC28C7Q28831506-E61D0701-1321-4E59-95D6-F62C2F4B9E0EQ30378369-F73E2C9B-677A-473A-B175-4B02FB347A1EQ30587663-D782CF32-B254-4564-A46F-B5629C82EBE4Q30620850-8408242A-C42B-4789-BDB7-B26847675F98Q33301926-81D3C9A1-CC48-4675-9F6D-E096E5048AD4Q33439378-D36FB9FF-83B5-4739-A1B1-0963AC4685C2Q33560154-024913EC-328E-4FD3-BEAF-093C94CAA201Q33623783-7D1EE63D-26BF-42F5-8B43-263A43CE858EQ33817804-7578A45A-C1E7-4FE6-9B87-E1A4CE99C146Q33869857-2A01938C-3A41-4863-A2B3-CE94FFEB62F1Q34060394-B0F7096C-DE91-482E-B817-42C03D95DD93Q34221421-410C745B-1945-4294-B3AA-4A30B14C26CBQ34239102-E48705ED-D8E7-41ED-907B-1F192436E478Q34243556-71F1AC88-AF4C-4304-8BE4-59AD95DE7411Q34245004-7EA83E31-0017-458A-818C-43FA292A0232Q34425147-88794CA2-2498-494B-A255-DE5918210135Q34477829-F2458030-0205-4994-910E-23D0CF85A26AQ34480265-39079215-1FC6-4A4F-8E2F-3E86B8CBE8EFQ34517628-32ADC86A-A616-4EF8-8110-100ADA97E95AQ34545935-4750804B-82E5-43EC-8A1D-F7ADBDD6C97AQ34643565-06C10579-0DD2-4602-BC9A-A6FD610AD3DFQ34720083-1B27ADD1-9885-4F1B-B933-881282D053B9Q34857261-0FB9ED45-CDC5-4816-8BD9-AA7B2730A3DCQ34913157-953D4340-08C4-4754-9B2C-971C5CD155A0Q35054122-7997C121-96E4-4B6A-9189-272BEBE4E2CAQ35058110-12830203-00EB-465B-9208-657692E0B88EQ35089868-97F40F9A-D8F3-478E-A615-5CDD043A0FA9Q35130226-E09A6274-D852-414B-8768-A9DB6C619E33Q35157981-28445962-1693-451C-A4F1-B6DEDDA604FA
P2860
Mitochondrial dysfunction and molecular pathways of disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mitochondrial dysfunction and molecular pathways of disease.
@ast
Mitochondrial dysfunction and molecular pathways of disease.
@en
Mitochondrial dysfunction and molecular pathways of disease.
@nl
type
label
Mitochondrial dysfunction and molecular pathways of disease.
@ast
Mitochondrial dysfunction and molecular pathways of disease.
@en
Mitochondrial dysfunction and molecular pathways of disease.
@nl
prefLabel
Mitochondrial dysfunction and molecular pathways of disease.
@ast
Mitochondrial dysfunction and molecular pathways of disease.
@en
Mitochondrial dysfunction and molecular pathways of disease.
@nl
P1476
Mitochondrial dysfunction and molecular pathways of disease.
@en
P2093
John Neustadt
Steve R Pieczenik
P356
10.1016/J.YEXMP.2006.09.008
P577
2007-01-18T00:00:00Z